Communiqués CannaPharmaRX, Inc.

Actions

CPMD

US13765D1090

Marché Fermé - OTC Markets Autres places de cotation 21:50:03 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,011 ^USD	-12,00%		-12,00%	+547,06%

25/06	CannaPharmaRX, Inc. déclare ses résultats pour le premier trimestre clos le 31 mars 2024	CI
04/06	CannaPharmaRX, Inc. conclut un accord de fourniture pluriannuel avec ICAN Green S.A. de C.V pour créer un réseau de distribution en Amérique latine	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23/06/23	AQ
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	22/12/22	NE
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	21/12/22	AQ
CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21/11/22	AQ
CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22/08/22	AQ
CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23/05/22	AQ
CANNAPHARMARX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	15/04/22	AQ
CANNAPHARMARX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	16/02/22	AQ
CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/11/21	AQ
CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/08/21	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure (form 8-K)	16/07/21	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22/06/21	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09/06/21	AQ
CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	17/05/21	AQ
CANNAPHARMARX : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	14/04/21	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	28/01/21	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22/01/21	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	12/01/21	AQ
CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	12/11/20	AQ
CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20/08/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués CannaPharmaRX, Inc.

Actions

CPMD

US13765D1090

Communiqués

Filtres